BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30664185)

  • 1. MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1.
    Zhang L; Zhang T; Deng Z; Sun L
    Oncol Rep; 2019 Mar; 41(3):1669-1677. PubMed ID: 30664185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-345 inhibits hepatocellular carcinoma metastasis by inhibiting YAP1.
    Zhang H; Liu H; Bi H
    Oncol Rep; 2017 Aug; 38(2):843-849. PubMed ID: 28677785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEG2 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting AKT pathway.
    Ying D; Ruan Y; Zhou X
    Gene; 2019 Mar; 687():1-8. PubMed ID: 30399427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
    Qu W; Wen X; Su K; Gou W
    J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
    Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
    Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.
    Yau WL; Lam CS; Ng L; Chow AK; Chan ST; Chan JY; Wo JY; Ng KT; Man K; Poon RT; Pang RW
    PLoS One; 2013; 8(3):e57882. PubMed ID: 23483935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.
    Sun X; Zhao S; Li H; Chang H; Huang Z; Ding Z; Dong L; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2017 Mar; 232(3):625-634. PubMed ID: 27333771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.
    Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q
    Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.